Influenza Vaccine in Lung Transplant Patients - Antibody
InfluenzaThis is a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This prospective, parallel study was done to investigate the responses to influenza vaccine in consecutive years.
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
InfluenzaThis a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibodies in lung transplant patients between seasons.
Invasive Pulmonary Aspergillosis and Severe Influenza
AspergillosisInfluenza1 moreInvasive pulmonary aspergillosis (IPA) has been reported in critically ill patients with influenza infection with a highly variable incidence between 1 to 21%. Studies investigating IPA in critically ill patients with influenza infection suffer limitations in their methods. It remains unknown whether patients with influenza are more at risk of IPA than other patients hospitalized in intensive care unit and whether patients with influenza who develop IPA have specific risk factors for this infection. Our study aims to determine the incidence of IPA in a large multicenter cohort and to identify risk factors for IPA in these patients.
Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive...
Invasive Pulmonary AspergillosisMoralityInvasive tracheobronchial aspergillosis (ITBA) is an uncommon, but severe clinical form of Invasive Pulmonary Aspergillosis (IPA) in which the fungal infection is entirely or predominantly confined to the tracheobronchial tree. In view of the limited data concerning critically ill patients admitted to the intensive care unit (ICU) with severe influenza associated with ITBA, the investigators decided to evaluate the differences between the clinical presentations of two invasive infections: ITBA and IPA without tracheobronchial involvement (No ITBA).
Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICU
ARDSCOVID-19 Acute Respiratory Distress Syndrome1 moreSince the beginning of the SARS CoV 2 pandemia, the SARS CoV 2 was frequently compared with the seasonal influenza virus. However, few studies compared patients presenting acute respiratory distress syndrome (ARDS) induced by these viruses, with results being discordant. Our study means to compare mortality and morbidity of patients hospitalized in an intensive care unit (ICU) with ARDS induced by SARS CoV-2 and seasonal influenza.
Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling...
AgingLittle is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older adults so the investigators enrolled adults ≥50 years.
Idylla IFV-RSV Panel Clinical Testing
Respiratory Tract InfectionsInfluenza2 moreThis clinical study will collect fresh samples and perform laboratory testing on fresh and archived samples as described in the protocol.
Cost of Illness Associated With Influenza in the UK
InfluenzaThe objective of this study is to describe the burden associated with influenza in the UK, from both primary and secondary care perspectives, and to stratify the burden by the annual degree of mismatch between predicted and actual virus strains.
Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer
Influenza AInfluenza B1 moreThe objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B & RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults...
InfluenzaTo determine if prophylactic supplementation with B. lactis HN019 reduces the risk of developing physician- and laboratory-confirmed influenza infection at any time during the 12-week supplementation period.